We are live on ! Find out more
VPC

Vestal Point Capital Portfolio holdings

AUM $3.58B
1-Year Est. Return 189.12%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+189.12%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
-$22.5M
Cap. Flow
-$89.9M
Cap. Flow %
-6.81%
Top 10 Hldgs %
48.68%
Holding
85
New
25
Increased
22
Reduced
17
Closed
16

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$62.7M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$57.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$34.5M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$33.4M
5
GPCR icon
Structure Therapeutics
GPCR
+$22.8M

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$67.5M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$65.7M
3
GMED icon
Globus Medical
GMED
+$61.6M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$53.5M
5
ONC
BeOne Medicines Ltd
ONC
+$49.9M

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
76
DELISTED
Exact Sciences
EXAS
– –
-925,000
Closed -$39.1M
FULC icon
77
Fulcrum Therapeutics
FULC
$297M
– –
-1,160,000
Closed -$7.19M
GMED icon
78
Globus Medical
GMED
$11.2B
– –
-900,000
Closed -$61.6M
IMNM icon
79
Immunome
IMNM
$2.83B
– –
-1,000,000
Closed -$12.1M
INSP icon
80
Inspire Medical Systems
INSP
$1.74B
– –
-60,000
Closed -$8.03M
IOVA icon
81
Iovance Biotherapeutics
IOVA
$2.87B
– –
-300,000
Closed -$2.41M
NAMS icon
82
NewAmsterdam Pharma
NAMS
$3.34B
– –
-25,000
Closed -$480K
PCRX icon
83
Pacira BioSciences
PCRX
$997M
– –
-280,000
Closed -$8.01M
PRAX icon
84
Praxis Precision Medicines
PRAX
$10.1B
– –
-440,000
Closed -$18.2M
ONC
85
BeOne Medicines Ltd
ONC
$39.4B
– –
-350,000
Closed -$49.9M
1 2 3
4

Similar funds

WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
ACM
Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Vestal Point Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Vestal Point Capital held 85 positions worth $1.32B, down 1.7% from $1.34B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Vestal Point Capital withdrew a net $89.9M in Q3 2024, closing 16 positions and reducing 17 holdings. Its most notable exit was Globus Medical, an estimated $61.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 100% a quarter earlier.

Against the trend, Vestal Point Capital opened a new position in Agios Pharmaceuticals worth $33.8M.

  • Vestal Point Capital's largest Q3 2024 buy was Agios Pharmaceuticals: 760,000 shares worth $33.8M.
  • Vestal Point Capital added most to Insmed in Q3 2024, an estimated $62.7M increase.
  • Vestal Point Capital's biggest Q3 2024 reduction was Ascendis Pharma A/S, cutting an estimated $67.5M.
  • Vestal Point Capital fully exited Globus Medical in Q3 2024, selling an estimated $61.6M.
  • Vestal Point Capital's ten largest holdings make up 49% of its $1.32B portfolio in Q3 2024.
  • Vestal Point Capital opened 25 new positions and closed 16 in Q3 2024.
  • Vestal Point Capital's portfolio value fell 1.7% quarter-over-quarter to $1.32B.

Based on Vestal Point Capital's 13F filing for Q3 2024, filed 14 Nov 2024.